These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23499758)

  • 1. Effect of UDP-glucuronosyltransferase 1A8 polymorphism on raloxifene glucuronidation.
    Kokawa Y; Kishi N; Jinno H; Tanaka-Kagawa T; Narimatsu S; Hanioka N
    Eur J Pharm Sci; 2013 May; 49(2):199-205. PubMed ID: 23499758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9.
    Kishi N; Takasuka A; Kokawa Y; Isobe T; Taguchi M; Shigeyama M; Murata M; Suno M; Hanioka N
    Xenobiotica; 2016; 46(4):289-95. PubMed ID: 26247833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of raloxifene glucuronidation: potential role of UGT1A8 genotype on raloxifene metabolism in vivo.
    Sun D; Jones NR; Manni A; Lazarus P
    Cancer Prev Res (Phila); 2013 Jul; 6(7):719-30. PubMed ID: 23682072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
    Mizuma T
    Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Trdan Lusin T; Trontelj J; Mrhar A
    Drug Metab Dispos; 2011 Dec; 39(12):2347-54. PubMed ID: 21937736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation.
    Hanioka N; Oka H; Nagaoka K; Ikushiro S; Narimatsu S
    Arch Toxicol; 2011 Nov; 85(11):1373-81. PubMed ID: 21404072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.
    Kemp DC; Fan PW; Stevens JC
    Drug Metab Dispos; 2002 Jun; 30(6):694-700. PubMed ID: 12019197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
    Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
    Bernard O; Tojcic J; Journault K; Perusse L; Guillemette C
    Drug Metab Dispos; 2006 Sep; 34(9):1539-45. PubMed ID: 16790554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9.
    Kerdpin O; Elliot DJ; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2006 Dec; 34(12):1950-3. PubMed ID: 16985098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Study on Influences of UGT1A8 Gene Polymorphisms on Mycophenolate Mofetil Metabolism.
    Zhou Z; Lu Y; Song G; Wang Y; Chen J; Xiao C; Zhong L; Sun X; Peng Z; Wang X
    Exp Clin Transplant; 2018 Aug; 16(4):466-472. PubMed ID: 29025387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid positions 69-132 of UGT1A9 are involved in the C-glucuronidation of phenylbutazone.
    Nishiyama T; Fujishima M; Masuda Y; Izawa T; Ohnuma T; Ogura K; Hiratsuka A
    Arch Biochem Biophys; 2008 Oct; 478(1):75-80. PubMed ID: 18602884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue.
    Chouinard S; Tessier M; Vernouillet G; Gauthier S; Labrie F; Barbier O; Bélanger A
    Mol Pharmacol; 2006 Mar; 69(3):908-20. PubMed ID: 16339389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of pH in the glucuronidation of raloxifene, mycophenolic acid and ezetimibe.
    Chang JH; Yoo P; Lee T; Klopf W; Takao D
    Mol Pharm; 2009; 6(4):1216-27. PubMed ID: 19449843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intestinal glucuronidation in limiting hepatic exposure and bioactivation of raloxifene in humans and rats.
    Dalvie D; Kang P; Zientek M; Xiang C; Zhou S; Obach RS
    Chem Res Toxicol; 2008 Dec; 21(12):2260-71. PubMed ID: 19548350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes.
    Yamanaka H; Nakajima M; Katoh M; Yokoi T
    Drug Metab Dispos; 2007 Sep; 35(9):1642-8. PubMed ID: 17591679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
    Yuan L; Qian S; Xiao Y; Sun H; Zeng S
    Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
    Lévesque E; Delage R; Benoit-Biancamano MO; Caron P; Bernard O; Couture F; Guillemette C
    Clin Pharmacol Ther; 2007 Mar; 81(3):392-400. PubMed ID: 17339869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.